These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14571807)

  • 41. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
    Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F
    Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Local treatment of liver tumors].
    Pless TK; Skjoldbye BO
    Ugeskr Laeger; 2008 Apr; 170(16):1348-9. PubMed ID: 18433596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Percutaneous treatment of hepatocellular carcinoma].
    Brú C
    Rev Gastroenterol Mex; 1996; 61(4 Suppl 2):S90-3. PubMed ID: 9102790
    [No Abstract]   [Full Text] [Related]  

  • 44. [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization and percutaneous ethanol injection for recurrent small hepatocellular carcinoma].
    Xu ZM; Wang JH; Zhen ZJ; Chen HW; Cui WZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1626-8. PubMed ID: 17121718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of survival rates after bland arterial embolization and ablation versus surgical resection for treating solitary hepatocellular carcinoma up to 7 cm.
    Maluccio M; Covey AM; Gandhi R; Gonen M; Getrajdman GI; Brody LA; Fong Y; Jarnagin W; D'Angelica M; Blumgart L; DeMatteo R; Brown KT
    J Vasc Interv Radiol; 2005 Jul; 16(7):955-61. PubMed ID: 16002503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A case report of the local treatment against hepatocellular carcinoma (HCC) in consideration of the prospective living donor liver transplantation (LDLT)].
    Ishiko T; Beppu T; Doi H; Sugiyama S; Inomata Y; Egami H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1900-2. PubMed ID: 15553753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis.
    Poggi G; Gatti C; Teragni C; Delmonte A; Bernardo G
    Anticancer Res; 2004; 24(4):2419-21. PubMed ID: 15330193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients.
    Bruno R; Puoti M; Sacchi P; Filice C; Carosi G; Filice G
    J Hepatol; 2006; 44(1 Suppl):S146-50. PubMed ID: 16356582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Therapeutic response of untreatable hepatocellular carcinoma after application of the immune modulators IL-2, BCG and melatonin.
    Tomov B; Popov D; Tomova R; Vladov N; Den Otter W; Krastev Z
    Anticancer Res; 2013 Oct; 33(10):4531-5. PubMed ID: 24123026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Massive hepatic necrosis with gastric, splenic, and pancreatic infarctions after ethanol ablation for hepatocellular carcinoma.
    Da Ines D; Buc E; Petitcolin V; Flamein R; Lannareix V; Achim A; Garcier JM
    J Vasc Interv Radiol; 2010 Aug; 21(8):1301-5. PubMed ID: 20598566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of hepatocarcinoma].
    Martínez Cerezo FJ; Garreta J; Miralbés M; Balanzó J; Enríquez J
    Rev Esp Enferm Dig; 1996 Oct; 88(10):687-94. PubMed ID: 8983308
    [No Abstract]   [Full Text] [Related]  

  • 52. Interstitial therapies for liver tumors.
    Ravikumar TS
    Surg Oncol Clin N Am; 1996 Apr; 5(2):365-77. PubMed ID: 9019357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous ethanol injection in hepatocellular carcinoma.
    Livraghi T
    Digestion; 1998 Jul; 59 Suppl 2():80-2. PubMed ID: 9718431
    [No Abstract]   [Full Text] [Related]  

  • 54. Ultra-low-dose interleukin-2 in unresectable hepatocellular carcinoma.
    Palmieri G; Montella L; Milo M; Fiore R; Biondi E; Bianco AR; Martignetti A
    Am J Clin Oncol; 2002 Jun; 25(3):224-6. PubMed ID: 12040276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous alcohol injection of hepatocellular carcinoma.
    Salmi A
    Ann Intern Med; 1989 Mar; 110(6):494. PubMed ID: 2537594
    [No Abstract]   [Full Text] [Related]  

  • 56. Low doses of interleukin-2 can cure large bovine ocular squamous cell carcinoma.
    Den Otter W; Hill FW; Klein WR; Koten JW; Steerenberg PA; De Mulder PH; Rutten VP; Ruitenberg EJ
    Anticancer Res; 1993; 13(6B):2453-5. PubMed ID: 8135482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tumor perfusion with ethanol in advanced carcinoma of the esophagus].
    Monserat R; Bronstein M; Garnica E; Peraza W; Fuentes D; Palao R; Isern AM; Sánchez MJ; Fernández C; Grillo M
    G E N; 1988; 42(3):88-90. PubMed ID: 3152678
    [No Abstract]   [Full Text] [Related]  

  • 58. [Certain possible complications and side effects after the introduction of interleukin-2 in the scheme of treatment of surgical patients].
    Maĭborodin IV; Shevela AI; Egorov DV; Strel'tsova EI
    Vestn Khir Im I I Grek; 2009; 168(5):86-90. PubMed ID: 20020643
    [No Abstract]   [Full Text] [Related]  

  • 59. Regressive effect of intralesional injection of a moderate dose of recombinant interleukin-2 on carcinoma erysipeloides from gastric carcinoma.
    Hamamoto Y; Nagai K; Ichimiya M; Yamamoto K; Kinoshita E; Muto M
    Clin Exp Dermatol; 2001 Jan; 26(1):42-4. PubMed ID: 11260177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional low-dose interleukin-2 immunotherapy of lymph node micrometastasis in a guinea pig tumor model.
    Bier H; Haas I; Koldowski P
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(2):96-100. PubMed ID: 8177593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.